NAPROXEN TABLETS

The contract award SPE2D226F3025, issued by the Defense Logistics Agency under the parent IDIQ contract SPE2DX25D9822, is for a single line item of NAPROXEN TABLETS with a total contract value of $15.76, delivered under FOB Destination terms to USNS OSCAR V. PETERSON at FPO AE 09592. The awardee, DMS PHARMACEUTICAL GROUP INC, holds CAGE code 1UNB0 and is certified as a Women-Owned Small Business (WOSB) and Economically Disadvantaged Women-Owned Small Business (EDWOSB), with the NAICS code 325412 governing its size status. The product is identified by NSN 6505011868758 and associated NDC codes, and delivery is scheduled for July 15, 2026, with acceptance occurring at the destination point upon government inspection, governed by FAR 52.212-4 and 52.212-5 commercial items clauses. Payment will be processed via the Defense Finance and Accounting Service in Columbus, Ohio, under Fast Pay Net 15 terms, with invoicing directed to the specified remittance address. The contract is part of a larger $20 million IDIQ vehicle, though this specific order is a fixed-quantity, non-option order with zero variance allowed. The packaging and marking requirements reference manufacturer CAGE codes and NDCs but lack detailed MIL-STD specifications, while no explicit special requirements, quality standards, or technical documentation beyond commercial item compliance are present. The contracting officer is Lorinda Ferraiolo, with Catherine Gilbert serving as the local administrative contact; no COR or COTR is identified. The contract form and submission process follow Standard Form 1449 Rev 2/2012, with electronic submissions accepted via PDF, and the award was finalized on March 7, 2025, under a solicitation issued March 13, 2024.